Page 7 - Read Online
P. 7
28 Hypoalbuminemia: an underestimated, vital characteristic of hospitalized COVID-19 positive patients?
Giuliano Ramadori
Hepatoma Res 2020;6:28 http://dx.doi.org/10.20517/2394-5079.2020.43
29 Epidemiology of hepatocellular carcinoma in metabolic liver disease
Stefano Bellentani
Hepatoma Res 2020;6:29 http://dx.doi.org/10.20517/2394-5079.2020.10
30 Imaging biomarkers for predicting poor prognosis of hepatocellular carcinoma: a review
Yun Zhang, Zi-Xing Huang, Jie Chen, Yu-Jun Shi, Han-Yu Jiang, Li-Kun Cao, Bin Song
Hepatoma Res 2020;6:30 http://dx.doi.org/10.20517/2394-5079.2020.17
31 Impact of direct-acting antivirals on de novo occurrence of hepatocellular carcinoma in hepatitis C virus
patients
Ming Yang, Ruilan Ma, Yuan Huang, Lai Wei
Hepatoma Res 2020;6:31 http://dx.doi.org/10.20517/2394-5079.2019.45
32 Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly
Giovanni Marasco, Antonio Colecchia, Matteo Milandri, Benedetta Rossini, Luigina Vanessa Alemanni, Elton
Dajti, Federico Ravaioli, Matteo Renzulli, Rita Golfieri, Davide Festi
Hepatoma Res 2020;6:32 http://dx.doi.org/10.20517/2394-5079.2019.54
33 Predictive factors for hepatocellular carcinoma recurrence after curative treatments
Giovanni Marasco, Federico Ravaioli, Amanda Vestito, Benedetta Rossini, Elton Dajti, Luigi Colecchia, Kamela
Gjini, Matteo Renzulli, Rita Golfieri, Davide Festi, Antonio Colecchia
Hepatoma Res 2020;6:33 http://dx.doi.org/10.20517/2394-5079.2020.01
34 Role of laparoscopic and robotic liver resection compared to open surgery in elderly hepatocellular
carcinoma patients: a systematic review and meta-analysis
Alberto Brolese, Marta Rigoni, Alessandro Vitale, Giovanni de Pretis, Ivo Avancini, Cecilia Pravadelli, Michela
Frisinghelli, Umberto Rozzanigo, Giacomo Luppi, Francesco Dionisi, Stefano Marcucci, Giovanni Viel, Paolo
Beltempo, Cristina Prezzi, Marco Frisini, Marco Brolese, Giandomenico Nollo, Francesco A. Ciarleglio
Hepatoma Res 2020;6:34 http://dx.doi.org/10.20517/2394-5079.2020.15
35 Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma
Jihane N. Benhammou, Jonathan Lin, Shehnaz K. Hussain, Mohamed El-Kabanya
Hepatoma Res 2020;6:35 http://dx.doi.org/10.20517/2394-5079.2020.16
36 Intraarterial and intravenous contrast enhanced CT and MR imaging of multi-step hepatocarcinogenesis
defining the early stage of hepatocellular carcinoma development
Satoshi Kobayashi, Kazuto Kozaka, Toshifumi Gabata, Osamu Matsui, Tetsuya Minami
Hepatoma Res 2020;6:36 http://dx.doi.org/10.20517/2394-5079.2020.24
37 Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis
Ze-long Yang, Ting Guo, Dong-Lie Zhu, Shi Zheng, Dan-Dan Han, Yong Chen
Hepatoma Res 2020;6:37 http://dx.doi.org/10.20517/2394-5079.2020.09
